New technique will help retinitis pigmentosa study

Article

Spanish researchers have used the induction of neuronal degeneration of intense light exposure in mice retina in an experimental model of retinitis pigmentosa.

Spanish researchers have used the induction of neuronal degeneration of intense light exposure in mice retina in an experimental model of retinitis pigmentosa. It is hoped that the work will lead to a greater understanding and detection of new factors and molecules related to degenerative processes of the retina.

The work studied microglial cells, which are involved in disease and damage of the nervous system. Ana Maria Santos Carro of the Department of Cell Biology at the University of Granada examined the distribution and response of the cells in the retina of the mouse from its embryonic development, postnal and adult stages by subjecting it to a neurodegenerative process, induced by intense light exposure.

Carro said: "It is important to get to know the response of the microglial cells against neurodegenerative, because such cells are practically involved in all the diseases and damages of the nervous system, including Parkinson and Alzheimer's, and knowing their behaviour in pathologic situations could be helpful in the design of therapeutic strategies."

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.